Dysregulated mesenchymal PDGFR-β drives kidney fibrosis.
- DOI
- 10.15252/emmm.201911021
- Published
- 2020 Mar 6
- Container
- EMBO molecular medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.15252/emmm.201911021,
title = {Dysregulated mesenchymal PDGFR-β drives kidney fibrosis.},
author = {Buhl EM and Djudjaj S and Klinkhammer BM and Ermert K and Puelles VG and Lindenmeyer MT and Cohen CD and He C and Borkham-Kamphorst E and Weiskirchen R and Denecke B and Trairatphisan P and Saez-Rodriguez J and Huber TB and Olson LE and Floege J and Boor P},
year = {2020},
journal = {EMBO molecular medicine},
doi = {10.15252/emmm.201911021},
url = {https://doi.org/10.15252/emmm.201911021}
}RIS
TY - JOUR TI - Dysregulated mesenchymal PDGFR-β drives kidney fibrosis. AU - Buhl EM AU - Djudjaj S AU - Klinkhammer BM AU - Ermert K AU - Puelles VG AU - Lindenmeyer MT AU - Cohen CD AU - He C AU - Borkham-Kamphorst E AU - Weiskirchen R AU - Denecke B AU - Trairatphisan P AU - Saez-Rodriguez J AU - Huber TB AU - Olson LE AU - Floege J AU - Boor P PY - 2020 JO - EMBO molecular medicine DO - 10.15252/emmm.201911021 UR - https://doi.org/10.15252/emmm.201911021 ER -
APA
EM, B., S, D., BM, K., K, E., VG, P., MT, L., CD, C., C, H., E, B., R, W., B, D., P, T., J, S., TB, H., LE, O., J, F., & P, B. (2020). Dysregulated mesenchymal PDGFR-β drives kidney fibrosis.. EMBO molecular medicine. https://doi.org/10.15252/emmm.201911021
Source records
- pubmed · retrieved 2026-09-25T01:59:34.305Z